The NIH’s National Institute of Arthritis and Musculoskeletal and Skin Diseases provided the funding to Adam Hacking, PhD, chief scientific officer, at OPM. The three-year grant will support research developing new approaches for the delivery of antibiotics through OPM’s 3D printed poly-ether-ketone-ketone implants.
More articles on devices:
Investor notes: 6 spine device company updates
Yale student scoliosis brace tracking device startup gets $100k
Vivex Biomedical acquires University of Miami Tissue Bank assets
